Sunday, August 03, 2014 11:56:21 AM
Can tell all, even if they show and or announce efficacy, it is worthless. First, if it were strong and explosive enough, we would have heard about it. So they way the testing is set up, it may or may not work and proof is difficult to show. Nothing has came from this company since April. Who knows what they have or have not worked on.
They certainly did not deserve huge raises, extra shares, etc... based on performance, which is nothing ! Really, in 15 years, what have they done, license another persons cells and failed at trials with them..
Back to stroke, even if you hear efficacy... sell on the news and be thrilled to do it. Any efficacy would be based on spleen (not shrinking from the cells).. if that is the case, MSC's would work too and any of the 20 plus cell companies will beat ATHX to the market.
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM